166 related articles for article (PubMed ID: 31613681)
1. K-Ras-ERK1/2 accelerates lung cancer cell development via mediating H3
Cheng Z; Li X; Hou S; Wu Y; Sun Y; Liu B
Pharm Biol; 2019 Dec; 57(1):701-709. PubMed ID: 31613681
[No Abstract] [Full Text] [Related]
2. Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1.
Zhang J; Liu M; Liu W; Wang W
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1207-1215. PubMed ID: 30942624
[TBL] [Abstract][Full Text] [Related]
3. K-ras-ERK1/2 down-regulates H2A.X
Dong C; Sun J; Ma S; Zhang G
BMC Cancer; 2019 May; 19(1):530. PubMed ID: 31151422
[TBL] [Abstract][Full Text] [Related]
4. The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer.
Li YH; Li YX; Li M; Song SW; Ge Y; Jin JY; Li XY; Tan XD; Ye J
Life Sci; 2020 Sep; 256():117936. PubMed ID: 32531376
[TBL] [Abstract][Full Text] [Related]
5. K-Ras
Zhang J; Liu W; Dong H; Wang W
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2048-2057. PubMed ID: 31126199
[No Abstract] [Full Text] [Related]
6. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
7. K-Ras-PI3K regulates H3K56ac through PCAF to elevate the occurrence and growth of liver cancer.
Gao X; Cheng Z; Yuan H; Zhao H
J Cell Physiol; 2020 Apr; 235(4):3905-3915. PubMed ID: 31642074
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Ras-ERK1/2 signaling promotes the development of uveal melanoma by downregulating H3K14ac.
Li Y; Sun W; Sun D; Yin D
J Cell Physiol; 2019 Sep; 234(9):16011-16020. PubMed ID: 30770563
[TBL] [Abstract][Full Text] [Related]
9. Ras-ERK1/2 Signaling Promotes The Development Of Osteosarcoma By Regulating H2BK12ac Through CBP.
Xu X; Yu H; Xu Y
Cancer Manag Res; 2019; 11():9153-9163. PubMed ID: 31695502
[TBL] [Abstract][Full Text] [Related]
10. Ras-ERK1/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac.
Tian P; Zhu Y; Zhang C; Guo X; Zhang P; Xue H
BMC Cancer; 2018 Dec; 18(1):1286. PubMed ID: 30577849
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenic role of K-Ras-ERK1/2 signaling in bladder cancer via inhibition of H1.2 phosphorylation at T146.
Fan L; Wang Y; Wang W; Wei X
J Cell Physiol; 2019 Nov; 234(11):21135-21144. PubMed ID: 31032946
[TBL] [Abstract][Full Text] [Related]
12. KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39.
Li Y; Yu P; Zou Y; Cai W; Sun W; Han N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4257-4265. PubMed ID: 31736361
[TBL] [Abstract][Full Text] [Related]
13. Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells.
Carón RW; Yacoub A; Mitchell C; Zhu X; Hong Y; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
Cell Cycle; 2005 Mar; 4(3):456-64. PubMed ID: 15655348
[TBL] [Abstract][Full Text] [Related]
14. Ras-ERK signalling represses H1.4 phosphorylation at serine 36 to promote non-small-cell lung carcinoma cells growth and migration.
Shi S; Zhang J; Liu M; Dong H; Li N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2343-2351. PubMed ID: 31184227
[TBL] [Abstract][Full Text] [Related]
15. Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16.
Wei Y; Wang F; Sang B; Xu Z; Yang D
Life Sci; 2019 May; 225():55-63. PubMed ID: 30946839
[TBL] [Abstract][Full Text] [Related]
16. Retracted: Ras-PI3K-AKT signaling promotes the occurrence and development of uveal melanoma by downregulating H3K56ac expression.
Li Y; Sun D; Sun W; Yin D
J Cell Physiol; 2019 Sep; 234(9):16032-16042. PubMed ID: 30770562
[TBL] [Abstract][Full Text] [Related]
17. Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.
Parikh N; Shuck RL; Nguyen TA; Herron A; Donehower LA
Mol Cancer Res; 2012 Jun; 10(6):845-55. PubMed ID: 22532587
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
Ko JC; Syu JJ; Chen JC; Wang TJ; Chang PY; Chen CY; Jian YT; Jian YJ; Lin YW
Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):383-91. PubMed ID: 26046675
[TBL] [Abstract][Full Text] [Related]
19. Ras-AKT signaling represses the phosphorylation of histone H1.5 at threonine 10 via GSK3 to promote the progression of glioma.
Sang B; Sun J; Yang D; Xu Z; Wei Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2882-2890. PubMed ID: 31307224
[No Abstract] [Full Text] [Related]
20. The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma.
Zuo Q; Shi M; Chen J; Liao W
Biomed Pharmacother; 2011 Jun; 65(3):168-74. PubMed ID: 21602020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
